STOCKWATCH
·
Medical/Dental Instruments
Quarterly ResultMay 8, 2026, 07:03 AM

LENSAR Q1 Net Income $36.3M; Revenue Down 5% to $13.4M

AI Summary

LENSAR reported Q1 2026 financial results, showing a net income of $36.3 million, or $1.56 per basic share, a significant improvement from a $27.3 million net loss in Q1 2025. This turnaround was largely due to $10.0 million in acquisition-related income from a terminated merger and $23.9 million from warrant liabilities. Total revenue decreased 5% to $13.4 million, primarily due to lower system sales, though recurring revenue grew 9% to $12.6 million. The company placed 7 ALLY Systems, bringing the total installed base to 440, and expects system placements to recover following the resolution of merger uncertainty.

Key Highlights

  • Net income was $36.3 million ($1.56/share) in Q1 2026, up from a $27.3 million net loss in Q1 2025.
  • Total revenue decreased 5% to $13.4 million in Q1 2026 from $14.2 million in Q1 2025.
  • Recurring revenue increased 9% to $12.6 million, representing 94% of total revenue.
  • 7 ALLY Systems were placed in Q1 2026, with a backlog of 11 systems.
  • Total installed laser base grew 12% to 440 systems as of March 31, 2026.
  • Selling, general, and administrative expenses decreased 77% to $2.5 million.
  • EBITDA was $37.3 million in Q1 2026, compared to ($26.4) million in Q1 2025.
  • Cash, cash equivalents, and investments were $13.5 million as of March 31, 2026.
LNSR
Medical/Dental Instruments
LENSAR, Inc.

Price Impact